Cancer Drugs Approved on the Basis of a Surrogate End Point and Subsequent Overall Survival: An Analysis of 5 Years of US Food and Drug Administration Approvals.
作者信息
Kim Chul, Prasad Vinay
机构信息
Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
Division of Hematology and Medical Oncology, Knight Cancer Center, Oregon Health and Sciences University, Portland.
出版信息
JAMA Intern Med. 2015 Dec;175(12):1992-4. doi: 10.1001/jamainternmed.2015.5868.
Abstract
摘要
Zotero 插件